Skip to main content
Supplement ScienceSupplementScience
meta analysis2,149 participants

CoQ10 for Heart Failure: 2017 Meta-Analysis of 14 RCTs

·

This content is for informational purposes only and does not constitute medical advice. Statements about dietary supplements have not been evaluated by the FDA and are not intended to diagnose, treat, cure, or prevent any disease. Individual results may vary — consult your healthcare provider before starting any supplement. Full disclaimer

The 2017 review of 14 trials (2,149 participants) reported lower mortality and better exercise capacity with CoQ10, but...

The 2017 review of 14 trials (2,149 participants) reported lower mortality and better exercise capacity with CoQ10, but no significant improvement in ejection fraction or NYHA class. Q-SYMBIO found fewer major cardiovascular events over two years when CoQ10 was added to standard heart-failure care. These findings do not establish routine use for everyone.

Key Findings

  • Lei and Liu pooled 14 randomized trials involving 2,149 people with heart failure; mortality was lower with CoQ10 (risk ratio 0.69, 95% CI 0.50–0.95). [2]
  • The 2017 review did not find a significant pooled improvement in left-ventricular ejection fraction or NYHA functional class. The previously quoted 3.67-percentage-point result came from a different review. [2]
  • Exercise-capacity results favored CoQ10, but studies differed and the article’s abstract contains internally inconsistent numerical entries; its results and conclusion need to be read together. [2]
  • In Q-SYMBIO, the primary major cardiovascular event endpoint occurred in 15% of the CoQ10 group and 26% of the placebo group over two years (hazard ratio 0.50, 95% CI 0.32–0.80). These are different effect measures. [1]
  • Q-SYMBIO studied 100 mg three times daily in 420 patients with moderate-to-severe heart failure, in addition to standard therapy; short-term endpoints were not significantly different. [1]

Study Details

The effect of coenzyme Q10 on morbidity and mortality in chronic heart failure: results from Q-SYMBIO
Mortensen SA, Rosenfeldt F, Kumar A, et al. — JACC: Heart Failure (2014)
With standard therapy, 100 mg three times daily for two years: primary events 15% versus 26%, hazard ratio 0.50 (95% CI 0.32–0.80); cardiovascular mortality 9% versus 16%.
420 participantsHigh

Practical Takeaway

CoQ10 is a possible adjunct to discuss with a cardiologist, not a substitute for guideline-directed heart-failure care. The cited evidence does not establish an optimal dose for all patients, a severity-based dosing rule or that lower-dose ubiquinol reproduces the outcomes of ubiquinone trials. CoQ10 can interact with warfarin and insulin. Statin use alone is not a reason everyone needs it. [1–3]

Summary

A systematic review and meta-analysis of 14 randomized controlled trials examining the effects of coenzyme Q10 supplementation on heart failure symptoms, left ventricular ejection fraction, and mortality in 2,149 heart failure patients.

Related Supplements

Coenzyme Q10 (CoQ10)

Related Conditions

Energy & FatigueBlood PressureLongevity & Healthy AgingHeart HealthChronic Fatigue SyndromeFertilityMigrainesMuscle Building

Product Reviews

Best CoQ10 Supplements
See our ranked picks →

Learn More

Form Comparison Table for Every Major Vitamin & Mineral
C15:0 Benefits: What to Know About Pentadecanoic Acid
Calcium Alpha-Ketoglutarate Benefits: Longevity, Biological Age, and What We Know

Frequently Asked Questions

Does CoQ10 help with heart failure?

Some trials suggest benefit as an adjunct, including fewer cardiovascular events in Q-SYMBIO. The 2017 meta-analysis reported lower mortality but no significant pooled ejection-fraction or NYHA-class improvement. NCCIH describes the overall heart-failure evidence as inconclusive; treatment decisions belong with the cardiology team. [1–3]

Evidence:Study (2014)[#1]. See full reference list below.

How much CoQ10 should heart failure patients take?

Q-SYMBIO used 100 mg three times daily alongside standard treatment. That study regimen is not a universal recommendation, and the review did not establish an optimal dose or a rule that more severe disease needs more CoQ10. Discuss the actual preparation, medicines and monitoring with a cardiologist. [1–3]

Evidence:Study (2014)[#1]. See full reference list below.

Should I take CoQ10 if I am on a statin?

Not automatically. Statins can lower circulating CoQ10, but that does not prove that supplementation prevents or treats muscle symptoms. NCCIH notes that the overall evidence does not support CoQ10 for statin-related muscle pain. Report symptoms to the prescriber rather than stopping the statin or treating them independently. [3]

Evidence:Study (2026)[#3]. See full reference list below.

What is the difference between ubiquinol and ubiquinone CoQ10?

They are reduced and oxidized forms that the body interconverts. Absorption depends on the finished formulation, and a higher blood level does not prove better clinical outcomes. The cited heart-failure trials do not establish a 3–6-fold universal absorption advantage or that lower-dose ubiquinol is clinically equivalent. [1–3]

Evidence:Study (2014)[#1]. See full reference list below.

Continue Reading

Supplement Guide

Coenzyme Q10 (CoQ10)

CoQ10 may be considered as an adjunct in selected clinical settings. It is not a substitute for heart-failure or cholesterol treatment, and neither form is proven universally superior.

Product Comparison

Best CoQ10 Supplements

See our ranked picks

Condition Guide

Energy & Fatigue

References

  1. Mortensen SA, Rosenfeldt F, Kumar A, et al. (2014). The effect of coenzyme Q10 on morbidity and mortality in chronic heart failure: results from Q-SYMBIO: a randomized double-blind trial. JACC: Heart Failure. DOI PubMed
  2. Lei L, Liu Y (2017). Efficacy of coenzyme Q10 in patients with cardiac failure: a meta-analysis of clinical trials. BMC Cardiovascular Disorders. DOI PubMed
  3. National Center for Complementary and Integrative Health (2026). Coenzyme Q10. NCCIH.